Found 0 matching trials
Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy. PHASE3 The main purpose of
* To observe the overall survival of patients with res...
Show More Location
Multiple Locations
Learn More & Join Trial
Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial PHASE2 This is an open-label, phase II study in patients with resectable and borde...
Show More Location
Froedtert & the Medical College of Wisconsin
Learn More & Join Trial
A Trial Using Transcriptomic Signatures to Personalize Neoadjuvant Chemotherapy (NAC) for Patients With Resectable Borderline Pancreatic Adenocarcinoma (PDAC) NA Pancreatic cancer exhibits significant heterogeneity, which poses a major c...
Show More Location
Multiple Locations
Learn More & Join Trial
24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC PHASE2 The purpose of this research is to study the effects and safety of alternat...
Show More Location
Dartmouth-Hitchcock Medical Center
Learn More & Join Trial
Neoadjuvant Treatment vs Upfront Surgery for Left-Sided Pancreatic Cancer PHASE3 Pancreatic cancer is one of the most treatment resistant malignancies, ofte...
Show More Location
Helsinki University Central Hospital
Learn More & Join Trial
Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer PHASE2 This phase II trial studies how well combination chemotherapy before and af...
Show More Location
Smilow Cancer Hospital at Fairfield
Learn More & Join Trial
Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5) PHASE1 Since patients with (borderline) resectable pancreatic cancer have a limite...
Show More Location
Amsterdam University Medical Center
Learn More & Join Trial
Neoadjuvant Modified FOLFIRINOX in Borderline Resectable Pancreatic Cancer PHASE2 The purpose of this study is to assess the feasibility and efficacy outcome...
Show More Location
Asan Medical Center, University of Ulsan College of Medicine
Learn More & Join Trial
Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44) PHASE2 This is a prospective, randomized phase II trial. The aim of this study is ...
Show More Location
Institut Bergonié
Learn More & Join Trial
Evaluation Contact X-ray Brachytherapy for Rectal Preservation in Intermediate Substage Rectal Adenocarcinoma PHASE3 Indication : Adult patients with intermediate low or mid rectal adenocarcin...
Show More Location
Institut Sainte Catherine
Learn More & Join Trial